Related Experiment Video
Updated: Oct 22, 2025

Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Creutzfeldt-Jakob disease with neuroleptic malignant syndrome
Julija Čiauškaitė1, Ieva Puleikytė1, Simonas Jesmanas2
1Department of Neurology Medical Academy Lithuanian University of Health Sciences Kaunas Lithuania.
Abstract:
Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine.
Related Concept Videos
Antipsychotic Drugs: Typical and Atypical Agents
Parkinson's Disease: Overview
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Neural Regulation
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

